Search Results - "Nikcevich, D. A."

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma by Inwards, D.J., Fishkin, P.A., LaPlant, B.R., Drake, M.T., Kurtin, P.J., Nikcevich, D.A., Wender, D.B., Lair, B.S., Witzig, T.E.

“…We conducted this trial to determine the maximum tolerated dose (MTD) of temsirolimus added to an established regimen comprised of rituximab and cladribine for…”
Get full text

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group by Jatoi, A., Murphy, B. R., Foster, N. R., Nikcevich, D. A., Alberts, S. R., Knost, J. A., Fitch, T. R., Rowland, K. M.

“…Purpose: The synergic combination of oxaliplatin and capecitabine has demonstrated activity against various gastrointestinal cancers, including colon cancer…”
Get full text

Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma by Ansell, S M, Tang, H, Kurtin, P J, Koenig, P A, Nowakowski, G S, Nikcevich, D A, Nelson, G D, Yang, Z, Grote, D M, Ziesmer, S C, Silberstein, P T, Erlichman, C, Witzig, T E

“…Follicular lymphoma exhibits intratumoral infiltration by non-malignant T lymphocytes, including CD4+CD25+ regulatory T (T reg ) cells. We combined denileukin…”
Get full text

Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group by Giordano, K.F., Jatoi, A., Stella, P.J., Foster, N., Tschetter, L.K., Alberts, S.R., Dakhil, S.R., Mailliard, J.A., Flynn, P.J., Nikcevich, D.A.

“…Background: Previous studies suggest that the combination of docetaxel and capecitabine are worthy of further testing in patients with metastatic…”
Get full text

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma by Inwards, D.J., Fishkin, P.A., LaPlant, B.R., Drake, M.T., Kurtin, P.J., Nikcevich, D.A., Wender, D.B., Lair, B.S., Witzig, T.E.

Get full text

Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double-blind NCCTG trial N04C7 by Nikcevich, D. A., Grothey, A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Novotny, P. J., Windschitl, H. E., Loprinzi, C. L.

“…Abstract only…”
Get full text

Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice by Nikcevich, D A, Duffie, G P, Young, M R, Ellis, N K, Kaufman, G E, Wepsic, H T

“…Systemic administration of a single dose (300 mg/kg) of cyclophosphamide (Cy) induced the appearance of a population of suppressor cells in the bone marrow and…”
Get more information

Stimulation of prostaglandin-dependent macrophage suppressor cells by the subcutaneous injection of polyunsaturated fatty acids by Ellis, N K, Young, M R, Nikcevich, D A, Newby, M, Plioplys, R, Wepsic, H T

“…Polyunsaturated fatty acids (PUFAs), in the form of pure linoleic, linolenic, or arachidonic acid, were injected subcutaneously into male C57Bl/6 mice daily…”
Get more information

Image of the month by Nikcevich, Daniel A., Abramson, Murray A.

“…GASTROENTEROLOGY 1998;114:238…”
Get full text

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma by Inwards, D J, Fishkin, P A, LaPlant, B R, Drake, M T, Kurtin, P J, Nikcevich, D A, Wender, D B, Lair, B S, Witzig, T E

Get full text

Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis by Nikcevich, D A, Young, M R, Ellis, N K, Newby, M, Wepsic, H T

“…Indomethacin (IN) was administered to untreated or to cyclophosphamide (CY) treated C57B1/6 mice to study the roles of prostaglandins in regulating…”
Get more information

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy : A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3) by RAO, Ravi D, MICHALAK, John C, SLOAN, Jeff A, LOPRINZI, Charles L, SOORI, Gamini S, NIKCEVICH, Daniel A, WARNER, David O, NOVOTNY, Paul, KUTTEH, Leila A, WONG, Gilbert Y

“…The antiepileptic agent, gabapentin, has been demonstrated to relieve symptoms of peripheral neuropathy due to various etiologies. On the basis of these data,…”
Get full text

Surgical practice patterns following NCCTG N0338 “Phase II trial of docetaxel and darboplatin administered every two weeks as induction therapy for stage II and stage III breast cancer.” by Apsey, H., Roy, V., Pockaj, B., Northfelt, D., Sticca, R., Nikcevich, D. A., Mattar, B., Fitch, T., Perez, E. A.

“…Abstract only 623 Background: Neoadjuvant therapy plays an important role in breast cancer treatment. Unlike patients who undergo surgery followed by adjuvant…”
Get full text

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9) by Jatoi, Aminah, Ritter, Howard L, Dueck, Amylou, Nguyen, Phuong L, Nikcevich, Daniel A, Luyun, Ronnie F, Mattar, Bassam I, Loprinzi, Charles L

“…Abstract Purpose This study tested whether infliximab, a chimeric IgG1kappa monoclonal antibody that blocks tumor necrosis factor (TNF) alpha,…”
Get full text

Evaluation of the effect of intravenous calcium and magnesium (CaMg) on chronic and acute neurotoxicity associated with oxaliplatin: Results from a placebo-controlled phase III trial by Grothey, A., Nikcevich, D. A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Windschilt, H. E., Zhao, X., Loprinzi, C. L.

“…Abstract only 4025 Background: Cumulative sNT is the dose-limiting toxicity of oxaliplatin which commonly leads to early discontinuation of oxaliplatin-based…”
Get full text

Final results of NCCTG N0489: Epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma by Micallef, I. N., Maurer, M. J., Nikcevich, D. A., Cannon, M. W., Schaefer, E. W., Moore, D. F., Kurtin, P., Witzig, T. E.

“…Abstract only 8508 Background: A prior pilot study of epratuzumab (Immunomedics) and rituximab in combination with CHOP chemotherapy (ER-CHOP) in untreated…”
Get full text

A phase II study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cell lymphoma by Micallef, I. N., Maurer, M. J., Nikcevich, D. A., Cannon, M., Moore, D. F., Kurtin, P., Witzig, T. E.

“…Abstract only…”
Get full text

A phase II trial of carboplatin (C) and nab-paclitaxel (ABI-007-nab-P) in patients with unresectable stage IV melanoma: Final data from N057E by Markovic, S. N., Suman, V. J., Kottschade, L. A., Amatruda, T., McWilliams, R. R., Dakhil, S. R., Nikcevich, D. A., Morton, R. F., Fitch, T. R., Jaslowski, A. J.

“…Abstract only 9055 Background: There is increasing evidence that paclitaxel and carboplatin are clinically active in the treatment of metastatic melanoma (MM)…”
Get full text

N0338 phase II trial of docetaxel and carboplatin administered every two weeks as induction therapy for stage II or III breast cancer by Roy, V., Pockaj, B. A., Northfelt, D. W., Allred, J. B., Liu, H., Nikcevich, D. A., Mattar, B. I., Perez, E. A.

“…Abstract only…”
Get full text

A phase II trial of carboplatin and ABI-007 in patients with unresectable stage IV melanoma, N057E by Kottschade, L. A., Suman, V. J., Amatruda, T., McWilliams, R. R., Dakhil, S. R., Nikcevich, D. A., Morton, R. F., Fitch, T. R., Jaslowski, A. J., Markovic, S. N.

“…Abstract only…”
Get full text